Methoxymethane

Methoxymethane

SCHEMBL148039

COC.OB(O)F.OB(O)F.OB(O)F.OB(O)F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxymethane SCHEMBL10713896 1.00
SCHEMBL6325345 0.82
SCHEMBL9631220 0.82
Water SCHEMBL6511940 0.79
Methoxymethane SCHEMBL47851 0.78
Boric Acid SCHEMBL28115304 0.78
Methyl Alcohol SCHEMBL9393721 0.78 TSHR (0.38)
SCHEMBL3629581 0.78 LMNA (0.43)
SCHEMBL25487 0.78
SCHEMBL633724 0.78 LMNA (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534427-B1 AN ADAMANTYL CATALYST SYSTEM LUCITE INT UK LTD (GB) 2009-10-21 EP claimed
US-20060106259-A1 Phospha-adamantane(s) catalytic system LUCITE INTERNATIONAL UK LIMITED (GB) 2006-05-18 US claimed
EP-1534427-A1 AN ADAMANTYL CATALYTIC SYSTEM Lucite International UK Limited (GB) 2005-06-01 EP claimed
WO-2004014552-A1 A PHOSPHA-ADAMANTANE (S) CATALYTIC SYSTEM LUCITE INTERNATIONAL UK LIMITED (GB) 2004-02-19 WO claimed
US-20240228509-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC (US) 2024-07-11 US disclosed
US-20230399340-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC (US) 2023-12-14 US disclosed
US-20230218559-A1 Compositions and Methods for Treating Aging and Age-Related Diseases and Symptoms UNIV CALIFORNIA (US) 2023-07-13 US disclosed
US-20230183261-A1 Macrocyclic MCL-1 Inhibitors and Methods of Use ABBVIE INC (US) 2023-06-15 US disclosed
EP-3750896-B1 CHIRAL TETRADENTATE LIGAND, METHOD FOR PRODUCING SAME AND TRANSITION METAL COMPLEX OF SAID CHIRAL TETRADENTATE LIGAND TAKASAGO PERFUMERY CO LTD (JP) 2022-06-29 EP disclosed
EP-3988555-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2022-04-27 EP disclosed
US-20210292339-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC (US) 2021-09-23 US disclosed
CN-113082009-A Compositions and methods for treating aging and age-related diseases and conditions 加利福尼亚大学董事会 2021-07-09 CN disclosed
WO-1999059721-A1 CATALYTIC ASYMMETRIC HYDROGENATION, HYDROFORMYLATION, AND HYDROVINYLATION VIA TRANSITION METAL CATALYSTS WITH PHOSPHINES AND PHOSPHITES THE PENN STATE RESEARCH FOUNDATION (US) 1999-11-25 WO disclosed
US-5936127-A Asymmetric synthesis and catalysis with chiral heterocyclic compounds THE PENN STATE RESEARCH FOUNDATION (US) 1999-08-10 US disclosed
EP-0918781-A4 ASYMMETRIC SYNTHESIS CATALYZED BY TRANSITION METAL COMPLEXES WITH CYCLIC CHIRAL LIGANDS PENN STATE RES FOUND (US) 1999-07-28 EP disclosed
EP-0918781-A1 ASYMMETRIC SYNTHESIS CATALYZED BY TRANSITION METAL COMPLEXES WITH CYCLIC CHIRAL LIGANDS THE PENN STATE RESEARCH FOUNDATION (US) 1999-06-02 EP disclosed
WO-1999024443-A2 CATALYSTS FOR ASYMMETRIC SYNTHESIS CONTAINING RIGID CHIRAL LIGANDS THE PENN STATE RESEARCH FOUNDATION (US) 1999-05-20 WO disclosed
WO-1998030569-A1 ASYMMETRIC SYNTHESIS AND CATALYSIS WITH CHIRAL HETEROCYCLIC COMPOUNDS THE PENN STATE RESEARCH FOUNDATION (US) 1998-07-16 WO disclosed
WO-1997047633-A9 ASYMMETRIC SYNTHESIS CATALYZED BY TRANSITION METAL COMPLEXES WITH CYCLIC CHIRAL PHOSPHINE LIGANDS 1998-03-12 WO disclosed
WO-1997047633-A1 ASYMMETRIC SYNTHESIS CATALYZED BY TRANSITION METAL COMPLEXES WITH CYCLIC CHIRAL PHOSPHINE LIGANDS THE PENN STATE RESEARCH FOUNDATION (US) 1997-12-18 WO disclosed